Research Tools
Polyclonal Antibodies Against Equine Rhinitis A Virus 3AB, 3C and 3D Proteins
WARF: P07500US
Inventors: Ann Palmenberg, Svetlana Amineva, Aleksey Aminev
The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in polyclonal antibodies against several equine rhinitis A virus proteins.
Overview
Equine rhinitis A virus, formerly known as equine rhinovirus 1, causes a respiratory disease in horses similar to the common cold in humans. No vaccines against this virus are available commercially and no specific antiviral treatment exists.
The Invention
UW-Madison researchers have developed polyclonal antibodies against recombinant proteins from equine rhinitis A virus. The antibodies can be used for specific molecular recognition of the equine rhinitis A virus proteins in vitro or in vivo using experimental techniques such as ELISA (enzyme linked immunosorbent assay), Western assays, protein immunoprecipitation (IP) and confocal fluorescence microscopy.
Applications
- Studying equine rhinitis A virus proteins
- May lead to new means of detecting, preventing and treating equine rhinitis A virus infection
Key Benefits
- All reagents have been tested for efficacy.
- Most of the antibodies react with viral precursor proteins, in addition to the mature proteins against which they were raised.
Additional Information
For More Information About the Inventors
Related Technologies
Tech Fields
For current licensing status, please contact Jennifer Gottwald at [javascript protected email address] or 608-960-9854